NCT00018278已完成4 期
Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to locate electrophysiological markers and predictors of cognitive and clinical treatment response.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 55 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
早期 1 期
Neurophysiological and Acute Pharmacological Studies in FXS PatientsFragile X SyndromeNCT02998151Children's Hospital Medical Center, Cincinnati29
已完成
不适用
Treating Verbal Memory Deficits Following Chemotherapy for Breast CancerBreast Cancer TreatmentCognitive DeficitsNCT03017560Northwestern University45
已完成
4 期
Study of Medication and Placebo Response in Major DepressionDepressive Disorder, MajorNCT00229476University of California, Los Angeles60
已完成
不适用
Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's DiseaseParkinson's DiseaseNCT00912808Oregon Health and Science University23
已完成
不适用
The Effect of Acetylcholine on Memory and AttentionHealthyAlzheimer's DiseaseNCT00001977National Institute of Mental Health (NIMH)70